The role of «old age proteins» and endotelial dysfunction markers in diabetic foot syndrome development
https://doi.org/10.29413/ABS.2021-6.3.8
Abstract
Background. Diabetes mellitus has been the most common endocrine disease in the world for decades. The growth rate of this disease has become a global pandemic. With diabetes, the risk of developing macrovascular complications increases dramatically, this often leads to serious complications such as diabetic foot.
The aim of the study was to determine the levels of «old age proteins» and markers of endothelial dysfunction characteristic to the diabetic foot syndrome.
Materials and methods. The study was carried out in the Laboratory
of experimental and clinical biochemistry and immunology of the research Institute of Molecular medicine of the Chita State Medical Academy and included determining of endothelial dysfunction markers (homocysteine, endothelin, NOx, NO2, NO3), MMP-9, GDF-15/MIC-1, CCL11 by solid-phase enzyme immunoassay.
Result. Diabetic foot syndrome is characterized by the level of GDF-15/MIC-1 equal to 1440 PG/ml or more, and by NOx that equal to 20 mmol/l or more. When these thresholds are reached, the probability of developing diabetic foot syndrome in diabetic patients increases in 10 and 4 times, respectively, which is confirmed by the results of statistical analysis in the IBM SPSS Statistics Version 25.0 program.
Conclusions. Increased levels of GDF-15/MIC-1 protein and nitric oxide metabolites in patients with type II diabetes can be considered as predictors of diabetic foot syndrome. The inclusion of these indicators in the structure of the regression model allows us to diagnose the preclinical stage of diabetic foot syndrome, which in the future will allow us to optimize the management and treatment of these patients.
About the Authors
R. I. Damdinov
Chita State Medical Academy
Russian Federation
Russian Federation
Assistant of the Department of Anatomy with a course in Topographic Anatomy and Operative Surgery
672090, Chita, Gorky St., 39a, Russia
K. G. Shapovalov
Chita State Medical Academy
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of Anesthesiology, Resuscitation and Intensive Care
672090, Chita, Gorky St., 39a, Russia
N. I. Troitskaya
Chita State Medical Academy
Russian Federation
Russian Federation
Assistant of the Department of Hospital Surgery
672090, Chita, Gorky St., 39a, Russia
References
1. Standards of Medical Care in Diabetes-2021: Improving Care and Promoting Health in Populations. Diabetes Care. 2021; 44 (1): 7–14. doi.org/10.2337/dc21-S001
2. Standards of Medical Care in Diabetes-2021: Summary of Revisions. Diabetes Care. 2021; 44 (1): 4–6. doi.org/10.2337/dc21-Srev
3. Dedov II, Shestakova MV. Type 1 diabetes mellitus: realities and prospects. Moscow: Medicinskoe informacionnoe agentstvo. 2016 (In Russian)
4. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: IDF. 2017; 148
5. Dedov II, Shestakova MV, MayorovA Yu, Vikulova OK, Galstyan GR, Kuraeva TL. et al. Algorithms of specialized medical care for patients with diabetes mellitus. Diabetes. 2016; 19 (2): 104–112. doi:10.14341/DM2004116–17
6. Dedov II, Shestakova MV, Galstyan GR. Prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes. 2016; 19 (2):104–112. doi: 10.14341/DM2004116–17
7. Akhmetova ES, Lareva NV, Mudrov VA, Gergesova EE. Features of the course of pregnancy in gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of obstetrics and women’s deseases. 2017; 66 (4): 14–24. doi.org/10.17816/JOWD66414–24 (In Russian)
8. Dedov IA, Shestakova MV. Epidemiology of Diabetes Mellitus in the Russian Federation: Clinical and Statistical Analysis Based on Data from the Federal Register of Diabetes Mellitus. Diabetes. 2017; 20 (1): 13–41. doi.org/10.14341/DM8664 (In Russian)
9. Galstyan GR, Vikulova OK, Isakov MA, Zheleznyakova AV, Serkov AA, Egorova DN. et al. Epidemiology of diabetic foot syndrome and lower limb amputations in the Russian Federation according to the Federal Register of Diabetic Patients (2013–2016). Diabetes. 2018; 21 (3):170–177. doi: 10.14341/DM9688
10. Miyajima S, Shirai A, Yamamoto S. Risk factors for major amputations in diabetic foot gangrene patients. Diabetes Res ClinPract. 2006; 7 (3): 272–279. doi.org/10.1016/j.diabres.2005.07.005
11. Dedov II. Diabetes mellitus: development of technologies in diagnosis, treatment and prevention (plenary lecture). Diabetes. 2010; (3): 6–13 (In Russian)
12. Obolensky VN, Nikitin VG, Leval PSh, Ermolova DA, Molochnikov AYu, Ermolov AA. Medical and diagnostic algorithm for diabetic foot syndrome: standards and new technologies. Russian medical journal: surgery. 2012; (12): 585–598 (In Russian)
13. Cherdantsev DV, Nikolaeva LP, Stepanenko AV, Konstantinov EP. Diabetic macroangiopathies: methods of restoring blood flow. Fundamental’nye issledovaniya. 2010; (1): 95–99 (In Russian)
14. Brodsky IN, Deev RV. The place of angiogenic therapy in the treatment program for patients with critical lower limb ischemia. Medicinskij al’manah. Hirurgiya. 2013; 5 (29): 156–157. doi.org/10.21145 (In Russian)
15. Villeda S, Luo J, Mosher K et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477: 90–94. doi.org/10.1038/nature10357
16. Bitto A, Kaeberlein M. Rejuvenation: it’s in our blood. Cell Metab. 2014; 20: 2–4. doi.org/10.1016/j.cmet.2014.06.007
17. Castellano JM, Kirby ED, Wyss-Coray T. Blood-Borne Revitalization of the Aged Brain. JAMA Neurol. 2015; 72 (10): 1191–1194. doi.org/10.1001/jamaneurol.2015.1616
18. Kuznik BI, Guseva ES, Davydov SO, SmolyakovYuN, Tsybikov NN. Influence of «youth protein» GDF11 and «old age proteins» CCL11, GDF15, JAM-A on the state of cardiohemodynamic functions in women with essential hypertension. Arterial’naya gipertenziya. 2019; 25 (5): 527–539. doi.org/10.18705/1607-419X-2019-25-5-527-539 (In Russian)
19. Corre J, Hebraud B, Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl Med. 2013; 12: 946–952. doi.org/10.5966/sctm.2013–0055
20. Corre J, Labat E, Espagnolle N, Hébraud B, Avet-Loiseau H, Rousse M. et al. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res. 2012; 72: 1395–1406. doi.org/10.1158/0008–5472.CAN-11–0188
21. Eggers KM, Kempf T, Wallentin L, Wollert K, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in communitydwelling elderly individuals. Clin Chem. 2013; 59 (7): 1091–1098. doi.org/10.1373/clinchem.2012.201210
22. Wiklund F, Bennet A, Magnusson P, Eriksson U, Lindmark F, Wu L. et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010; 9 (6): 1057–1064. doi.org/10.1111/j.1474–9726.2010.00629.x
23. Levin GYa, Kudritskiy SYu, Izumrudov MR. Correlation of changes in haemorheology and microcirculation in diabetic foot syndrome. Regionarnoe krovoobrashchenie i mikrocirkulyaciya. 2011; 10 (3): 44–48. doi.org/10.24884/1682-6655-2011-10-3-44-48. (In Russian)
24. Сifte M, Ertug H, Parlak M, Akcurin G, Kardelen F. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction. Diab Vase Dis Res. 2014; 11 (1): 19–25. doi.org/10.1177/1479164113508564
25. Vlasov TD, Petrishchev NN, Lazovskaya OA. Endothelial dysfunction. Do we understand this term correctly? Bulletin of Anesthesiology and Reanimatology. 2020; 17 (2): 76–84. doi.org/10.21292/2078-5658-2020-17-2-76-84. (In Russian)
26. Vorobieva EN, Schumacher GI, Khoreva MA, Osipova IV. Endothelial dysfunction is a key link in the pathogenesis of atherosclerosis. Russian journal of cardiology. 2010; 82 (2): 84–91. (In Russian)
27. Mikhailichenko MI, Shapovalov KG, Mudrov VA, Gruzdeva OS. Dynamics of matrix metalloproteinases in local cold injury. Acta biomedical scientifica. 2019; 4 (5): 79–83. doi.org/10.29413/ABS.2019–4.5.13. (In Russian)
28. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2011. Available from: http://www.icmje.org. [date of access: 01.09.2021]
29. Lang TA, Altman DG. Statistical analyses and methods in the published literature: The SAMPL guidelines. Medical Writing. 2016; 25 (3): 31–36. doi.org/10.18243/eon/2016.9.7.4
30. Mudrov VA. Statistical analysis algorithms of quantitative features in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; (1): 140–150. (In Russian)
31. Mudrov VA. Statistical analysis algorithms of qualitative features in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; (1):151–163. (In Russian)
32. Mudrov VA. Algorithms for performing data correlation analysis in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; 2: 177–190. (In Russian)
33. Bulaeva NI, Golukhova EZ. Endothelial dysfunction and oxidative stress: a role in the development of cardiovascular pathology. Creative cardiology. 2013; 1: 14–22
34. Puzik SG. Endothelial dysfunction in the pathogenesis of arterial hypertension and the progression of atherosclerosis. Family medicine. 2018; 76 (2): 69–74
Review
For citations:
Damdinov R.I., Shapovalov K.G., Troitskaya N.I. The role of «old age proteins» and endotelial dysfunction markers in diabetic foot syndrome development. Acta Biomedica Scientifica. 2021;6(3):77-85. (In Russ.) https://doi.org/10.29413/ABS.2021-6.3.8
Views:
1170
.png)
Email this article 
